Description
Salicylohydrazide (CAS 936-02-7) is a high-purity organic compound with the molecular formula C7H8N2O2, widely utilized in pharmaceutical and biochemical research. This white to off-white crystalline powder, also known as 2-hydroxybenzohydrazide, exhibits excellent stability under standard laboratory conditions. With a molecular weight of 152.15 g/mol, it serves as a versatile building block in organic synthesis, particularly in the development of hydrazide-based derivatives. Our Salicylohydrazide is rigorously tested to ensure ≥98% purity (HPLC), making it ideal for sensitive applications. Suitable for use as a chelating agent or intermediate in medicinal chemistry, this product is packaged under inert conditions to guarantee long-term stability. Available in quantities from grams to kilograms, it comes with comprehensive analytical documentation including 1H NMR, FTIR, and mass spectrometry data.
Properties
- CAS Number: 936-02-7
- Complexity: 149
- IUPAC Name: 2-hydroxybenzohydrazide
- InChI: InChI=1S/C7H8N2O2/c8-9-7(11)5-3-1-2-4-6(5)10/h1-4,10H,8H2,(H,9,11)
- InChI Key: XSXYESVZDBAKKT-UHFFFAOYSA-N
- Exact Mass: 152.058577502
- Molecular Formula: C7H8N2O2
- Molecular Weight: 152.15
- SMILES: C1=CC=C(C(=C1)C(=O)NN)O
- Topological: 75.4
- Monoisotopic Mass: 152.058577502
- Synonyms: Salicylohydrazide, Benzoic acid, 2-hydroxy-, hydrazide, 213-311-3, 2-Hydroxybenzohydrazide, 936-02-7, Salicylhydrazide, 2-Hydroxybenzhydrazide, Salicyl hydrazide, Salicylic acid hydrazide, Salicyloyl hydrazide, Salicylic hydrazide, Salicyloylhydrazine, o-Hydroxybenzoylhydrazide, 2-Hydroxybenzoylhydrazide, 2-Hydroxybenzoylhydrazine, o-Hydroxybenzhydrazide, o-Hydroxylbenzhydrazide, Salicyclohydrazine, SALICYLIC ACID, HYDRAZIDE, Salicoyl hydrazide, o-Hydroxybenzoylhydrazine, o-Hydroxybenzoic acid hydrazide, 2-Hydroxybenzoic acid hydrazide, Salicycic acid hydrazide, 2-Hydroxy-benzoic acid hydrazide, NSC 652, MFCD00007599, CHEMBL170058, NSC-652, 2-???phenol, benzoylhydrazine, O-hydroxy, EINECS 213-311-3, o-Hydroxybenzoic hydrazide, SALICYLYL HYDRAZINE, 2-Hydroxybenzoic hydrazide, salicoylhydrazine, salicyloylhydrazone, 2-Hydroxybenzenecarboxylic acid hydrazide, salicyclic acid hydrazide, Maybridge1_007678, 2-Hydroxybenzoyl hydrazide, Salicyloyl hydrazide, 98%, R5T5F3Q8HR, SCHEMBL161525, NSC652, DTXSID0061321, HMS563E22, STR00212, BBL008416, BDBM50056886, SBB007759, SEW 04563, STK053411, AKOS000120449, CS-W004074, FS70124, DB-021200, NS00039577, S0242, ST45157965, EN300-18163, 2-Hydroxybenzhydrazide;2-Hydroxybenzoylhydrazine, BRD-K80800852-001-01-8, Z57241860, F1099-0053, InChI=1/C7H8N2O2/c8-9-7(11)5-3-1-2-4-6(5)10/h1-4,10H,8H2,(H,9,11
Application
Salicylohydrazide finds significant application as a key intermediate in the synthesis of antimicrobial and antiviral agents due to its bioactive hydrazide moiety. Researchers employ this compound in metal chelation studies, particularly for iron and copper ions, in biochemical assays. The pharmaceutical industry utilizes it as a precursor for developing novel hydrazone derivatives with potential therapeutic properties. Its phenolic hydroxyl group makes it valuable in polymer chemistry as a cross-linking agent or stabilizer.
Safety and Hazards
GHS Hazard Statements
- H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
- H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
- H335 (98%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Precautionary Statements
- P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
Hazard Classes and Categories
- Skin Irrit. 2 (100%)
- Eye Irrit. 2 (100%)
- STOT SE 3 (98%)
If you are interested or have any questions, please contact us at support@atomfair.com
Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.


Reviews
There are no reviews yet.